Please see the Full Important Safety Information, including Boxed WARNING regarding Suicidal Thoughts and Behaviors, in the first post below and Full Prescribing Information at: bit.ly/3nel5Jq.
WARNING: SUICIDAL THOUGHTS AND BEHAVIORS
• Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies.
• Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors.
• TRINTELLIX is not approved for use in pediatric patients.
INDICATION
TRINTELLIX is indicated for the treatment of Major Depressive Disorder (MDD) in adults.
This page is intended for use by U.S. healthcare professionals only.
©2024 Takeda Pharmaceuticals U.S.A., Inc. All rights reserved. 1-877-TAKEDA-7 (1-877-825-3327).
US-VOR-1570v1.0 09/24
Company Details
- Address
- And Used Under License By Takeda Pharmaceuticals America
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.trintellixhcp.com
Trintellix® (Vortioxetine) Questions
Trintellix® (Vortioxetine)'s website is https://www.trintellixhcp.com
Trintellix® (Vortioxetine)'s LinkedIn profile is https://www.linkedin.com/company/trintellixus
Trintellix® (Vortioxetine)'s industry is
Pharmaceutical Manufacturing
Trintellix® (Vortioxetine)'s top competitors are
Genesis Behavioral Health,
Systane,
Mccosh Films Inc.,
Pomelo Care,
Professional Nurse Editors & Statisticians, Llc,
Caplyta® (Lumateperone) Hcp,
Catholic Professionals Forum Of Metro Milwaukee,
Takeda,
Qelbree® (Viloxazine Extended-Release Capsules),
Dmke Motor.
Trintellix® (Vortioxetine)'s categories are Pharmaceutical Manufacturing
